Allograft rejection is a critical issue following solid organ transplantation (SOT).
Immunosuppressive therapies are crucial in reducing risk of rejection yet are accompanied …

Of all the therapeutic options available in Dermatology, few of them have the history,
effectiveness, and safety of phototherapy. Heliotherapy, NB-UVB, PUVA, and UVA1 are …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Background/Objectives: Graft-versus-host disease (GVHD) is a severe complication of
allogeneic hematopoietic stem cell transplantation (allo-HSCT) resulting from …

Background Extracorporeal photopheresis (ECP) treatment, mostly based on apheresis
technology, is used for immunomodulation in various diseases such as cutaneous T‐cell …

Extracorporeal photopheresis (ECP) is widely used for the treatment of cutaneous T‐cell
lymphoma, graft‐vs‐host disease, and other immune‐related conditions. To avoid clotting …

Abstract Introduction: The National Comprehensive Cancer Network and the European
Organization for Research and Treatment of Cancer recommend extracorporeal …

Background Due to development of chronic lung allograft dysfunction (CLAD), prognosis for
patients undergoing lung transplantation (LTx) is still worse compared to other solid organ …

Background Extracorporeal photopheresis (ECP) is frequently utilized in the treatment of
steroid-refractory acute and chronic graft-versus-host disease (GVHD). Although the …

Systemic steroids are still the first-line approach in acute graft-versus-host disease (aGvHD),
and the backbone of chronic GvHD management. Refractoriness to steroid represent a …